# Aytu Biopharma, Inc: Form DEF 14A, filed May 10, 2024

- Company: [Aytu Biopharma, Inc](/companies/aytu.md) (CIK 1385818)
- Form: DEF 14A
- Filed: 2024-05-10
- Accepted by EDGAR: May 10, 2024, 16:06 ET
- Period: 2024-06-26
- Accession: 0001437749-24-016003
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1385818/000143774924016003/aytu20240409_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1385818/000143774924016003/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1385818/000143774924016003/aytu20240409_def14a.htm

Filed May 10, 2024.
Source: SEC EDGAR, the filing index for accession 0001437749-24-016003. Last ingested by Listed: Oct 27, 2026, 16:32 ET. No prices; not investment advice.
